Every Form 4 that 60 Degrees Pharmaceuticals, Inc. (SXTP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SXTP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SXTP filings page.
60 DEGREES PHARMACEUTICALS, INC. President and CEO Geoffrey S. Dow reported an open-market purchase of Common Stock. On June 12, 2026, he bought 7,350 shares at an average price of $1.3784 per share. After this transaction, he directly owns 24,131 shares of the company’s Common Stock.
60 Degrees Pharmaceuticals reported that President and CEO Geoffrey Dow, who is also a director, bought 9,670 shares of its common stock on December 15, 2025 at $0.8024 per share. Following this purchase, he directly owns 59,618 common shares of the company.
60 Degrees Pharmaceuticals President and CEO Geoffrey Dow, who also serves as a director, reported buying additional common stock in December 2025. He acquired 9,350 shares on 12/10/2025 at $0.9504 per share and 3,613 shares on 12/11/2025 at $0.9184 per share. After these transactions, he directly owned 49,948 common shares of the company.